CIK 0001020214
- Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680262011
- Phone
- +1 925-288-6000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- 4 Exercise or conversion Chief Scientific Officer acquired 6,000 shares (option exercise)
- 4 Open-market sale Chief Medical Officer sold 1,189 shares at $4.15 ($4,934)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion President and CEO acquired 55,000 shares (option exercise)
- 4 Exercise or conversion Chief Scientific Officer acquired 21,000 shares (option exercise)
- 4 Exercise or conversion Chief Scientific Officer acquired 9,000 shares (option exercise)
- 4 Open-market sale Chief Financial Officer sold 17,150 shares at an average $6.80 ($116,612)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Legal Officer sold 8,541 shares at $5.63 ($48,043)
Page 19 of 36 · 701 filings